Curt Hartleben-Matkin
Ocular Proteomics (United States)(US)
Publications by Year
Research Areas
Glaucoma and retinal disorders, Retinal Diseases and Treatments, Corneal surgery and disorders, Ocular Diseases and Behçet’s Syndrome, Retinal Imaging and Analysis
Most-Cited Works
- → Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study(2014)21 cited
- The efficacy and safety of two fixed combinations: timolol-dorzolamide-brimonidine versus timolol-dorzolamide. A prospective, randomized, double-masked, multi-center, 6-month clinical trial.(2010)
- → A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure(2017)14 cited
- → A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination in Patients with Controlled Primary Open-Angle Glaucoma(2018)12 cited
- → Reproducibilidad de la prueba de sobrecarga hídrica(2015)10 cited
- → High prevalence of angle-closure glaucoma in Vogt-Koyanagi-Harada disease(2022)9 cited
- → Risk factors for secondary Glaucoma in patients with Vogt-Koyanagi-Harada disease(2022)5 cited
- → A 4-year retrospective study of add-on therapy to the fixed combination of dorzolamide/timolol for the treatment of POAG.(2014)4 cited
- → Reproducibility of the water drinking test(2015)4 cited
- → A phase III, randomized, clinical, crossover study to evaluate the non-inferiority of an ophthalmic solution of preservative-free latanoprost at 0.005% in patients with primary open-angle glaucoma(2018)2 cited